Abeona Therapeutics (ABEO) Tops Q3 EPS by 5c

Abeona Therapeutics (NASDAQ: ABEO) reported Q3 EPS of ($0.48), $0.05 better than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue
• BofA maintains underperform ratings on six BDC stocks